Published in Ann Rheum Dis on June 01, 1989
Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis. Ann Rheum Dis (1996) 0.75
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J (Clin Res Ed) (1986) 1.55
A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis. Arthritis Rheum (1988) 1.06
Drug-induced blood disorders. JAMA (1984) 1.03
Glandular fever-like illness associated with sulphasalazine. Postgrad Med J (1982) 0.96
Comparison of white blood cell dyscrasias during sulphasalazine therapy of rheumatoid arthritis and inflammatory bowel disease. Drugs (1986) 0.92
Mode of action of sulphasalazine: an alternative view. Lancet (1982) 0.91
How to ensure that guidelines are effective. BMJ (1995) 4.31
Cardiac outcome after peripheral vascular surgery. Comparison of general and regional anesthesia. Anesthesiology (1996) 3.65
Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J (Clin Res Ed) (1983) 2.63
Enteroscopic diagnosis of small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs. Lancet (1991) 2.37
Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group. Lancet (1992) 2.31
Malignant melanoma in Scotland 1979-1983. Lancet (1985) 2.30
Excision biopsy of malignant melanoma by general practitioners in south east Scotland 1982-91. BMJ (1992) 2.14
Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group. BMJ (1997) 2.08
Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis (1993) 2.05
External fixation versus conservative treatment for distal radial fractures in adults. Cochrane Database Syst Rev (2007) 2.03
Cutting waiting lists. BMJ (1991) 2.02
Illiteracy in rheumatoid arthritis patients as determined by the Rapid Estimate of Adult Literacy in Medicine (REALM) score. Rheumatology (Oxford) (2002) 2.00
Antibodies to neutrophil cytoplasmic antigens: serologic marker for Sweet's syndrome. J Am Acad Dermatol (1991) 1.98
Antiprostaglandin synthetase activity of nonsteroidal anti-inflammatory drugs and gastrointestinal micro-bleeding: a comparison of flurbiprofen with benoxaprofen. Ann Rheum Dis (1981) 1.97
Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J (Clin Res Ed) (1986) 1.88
Effect of disease modifying agents on the lipid profiles of patients with rheumatoid arthritis. Ann Rheum Dis (1997) 1.87
Percutaneous pinning for treating distal radial fractures in adults. Cochrane Database Syst Rev (2007) 1.82
Does second-line therapy affect the radiological progression of rheumatoid arthritis? Ann Rheum Dis (1984) 1.69
Post-irradiation morphoea. Br J Dermatol (1989) 1.69
Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial. Ann Rheum Dis (2004) 1.69
Leg wound complications associated with coronary revascularization. J Thorac Cardiovasc Surg (1981) 1.67
Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus. Br Med J (Clin Res Ed) (1986) 1.64
Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.63
Predominant generation of 15-lipoxygenase metabolites of arachidonic acid by epithelial cells from human trachea. Proc Natl Acad Sci U S A (1985) 1.59
Xanthomatosis secondary to lymphoedema. Trans St Johns Hosp Dermatol Soc (1970) 1.59
A rational approach to melanoma follow-up in patients with primary cutaneous melanoma. Scottish Melanoma Group. Br J Dermatol (1999) 1.57
Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs. Am J Gastroenterol (1991) 1.57
Surgical interventions for treating distal radial fractures in adults. Cochrane Database Syst Rev (2003) 1.57
Circular chloroplast DNA from Euglena gracilis. Proc Natl Acad Sci U S A (1971) 1.57
Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years. Br Med J (Clin Res Ed) (1986) 1.55
Misoprostol in patients taking non-steroidal anti-inflammatory drugs. BMJ (1995) 1.54
Which component of sulphasalazine is active in rheumatoid arthritis? Br Med J (Clin Res Ed) (1985) 1.51
A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question? Ann Rheum Dis (1985) 1.50
Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med (1998) 1.50
Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis. Ann Rheum Dis (1985) 1.49
Neurological abnormalities following open-heart surgery. J Thorac Cardiovasc Surg (1969) 1.48
Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazine. Br J Rheumatol (1987) 1.45
Surgical interventions for treating distal radial fractures in adults. Cochrane Database Syst Rev (2001) 1.44
Small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs for rheumatoid arthritis. Q J Med (1986) 1.44
Antineutrophil cytoplasmic antibody titres in patients with recent infection. Br J Rheumatol (1993) 1.42
The 'natural' history of active rheumatoid arthritis over 3-6 months--an analysis of patients enrolled into trials of potential disease-modifying anti-rheumatic drugs, and treated with placebo. Br J Rheumatol (1993) 1.42
The treatment of plantar warts in the home. A critical appraisal of a new preparation. Practitioner (1971) 1.42
Fluorescent lights, ultraviolet lamps, and risk of cutaneous melanoma. BMJ (1988) 1.41
A case of orbital myositis associated with rheumatoid arthritis. Ann Rheum Dis (2002) 1.40
Fibrin-ring granulomas: a non-specific reaction to liver injury? Histopathology (1991) 1.39
Availability of condoms in district general hospitals. BMJ (1990) 1.39
Pneumocystis carinii infection complicating cytotoxic therapy in two patients with lymphopenia, but a normal total white cell count. Br J Rheumatol (1992) 1.39
Rupture of an otherwise normal aortic valve. Report of two cases and review of the literature. J Thorac Cardiovasc Surg (1968) 1.39
Predictive value of interleukin 1 gene polymorphisms for surgery. Ann Rheum Dis (2000) 1.38
The dermatology out-patient service: a study of out-patient referrals in a Scottish population. Br J Dermatol (1984) 1.38
Sweet's syndrome: a clinicopathologic review of twenty-nine cases. J Am Acad Dermatol (1990) 1.36
Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet (1989) 1.34
The use of the Internet as a resource for health information among patients attending a rheumatology clinic. Rheumatology (Oxford) (2002) 1.33
Co-ordinated multidisciplinary approaches for inpatient rehabilitation of older patients with proximal femoral fractures. Cochrane Database Syst Rev (2001) 1.33
Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev (2003) 1.30
Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. Br J Rheumatol (1985) 1.30
Sulphasalazine: a 'new' antirheumatic drug. Br J Rheumatol (1984) 1.30
Effect of sulphasalazine on the radiological progression of rheumatoid arthritis. Ann Rheum Dis (1987) 1.29
Seventeen-year experience with routine shunting in carotid artery surgery. World J Surg (1979) 1.28
Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis Rheum (2008) 1.24
En bloc resection of colon cancer adherent to other organs. Am J Surg (1987) 1.23
A neutral protease in rheumatoid synovial fluid capable of attacking the telopeptide regions of polymeric collagen fibrils. Biochim Biophys Acta (1975) 1.23
A double blind, randomised, multicentre comparison of two doses of intravenous iloprost in the treatment of Raynaud's phenomenon secondary to connective tissue diseases. Ann Rheum Dis (1991) 1.20
HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA. Lancet (1984) 1.20
Clinical and laboratory studies of levamisole in patients with rheumatoid arthritis. Q J Med (1978) 1.19
Giant hogweed dermatitis. Scott Med J (1970) 1.19
Synthesis of macromolecules during induction of haemoglobin synthesis by erythropoietin. J Mol Biol (1969) 1.18
Geriatric rehabilitation following fractures in older people: a systematic review. Health Technol Assess (2000) 1.18
Identification of human herpesvirus 6-specific DNA sequences in two patients with non-Hodgkin's lymphoma. Leukemia (1988) 1.18
The gene responsible for Werner syndrome may be a cell division "counting" gene. Proc Natl Acad Sci U S A (1993) 1.17
Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion. Br J Cancer (1994) 1.16
Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum Dis (1988) 1.16
Co-ordinated multidisciplinary approaches for inpatient rehabilitation of older patients with proximal femoral fractures. Cochrane Database Syst Rev (2000) 1.14
Continued use of non-steroidal anti-inflammatory drugs: an index of clinical efficacy. Br J Clin Pharmacol (1978) 1.14
Conservative interventions for treating distal radial fractures in adults. Cochrane Database Syst Rev (2003) 1.14
Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis. Ann Rheum Dis (1997) 1.13
Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate? Br Med J (Clin Res Ed) (1983) 1.12
Ruptured abdominal aortic aneurysm. Surgical management. Arch Surg (1968) 1.11
Arteriosclerotic aneurysm of anomalous right subclavian artery. J Thorac Cardiovasc Surg (1970) 1.11
Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study. Ann Rheum Dis (1998) 1.10
Rehabilitation status: a measure of medicosocial dysfunction. Lancet (1988) 1.10
Recurrent focal myositis. Rheumatology (Oxford) (1999) 1.10
Site-specific melanocytic naevus counts as predictors of whole body naevi. Br J Dermatol (1988) 1.09
Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients? Ann Rheum Dis (1999) 1.09